{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T10:27:50Z","timestamp":1793528870171,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.euo.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:18:06Z","timestamp":1775899086000},"page":"1089-1097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrating Genomic Prostate Score with Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores to Predict Biochemical Recurrence after Radical Prostatectomy"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1633-784X","authenticated-orcid":false,"given":"Yu","family":"Ozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Covas","family":"Moschovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Montesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Bubishate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shady","family":"Saikali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Boger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Roof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.03.003_b0005","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2016.08.065","article-title":"The CAPRA score at 10 years: contemporary perspectives and analysis of supporting studies","volume":"71","author":"Brajtbord","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.003_b0010","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1097\/01.ju.0000158155.33890.e7","article-title":"The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy","volume":"173","author":"Cooperberg","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.03.003_b0015","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/cncr.22262","article-title":"Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy","volume":"107","author":"Cooperberg","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2026.03.003_b0020","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.eururo.2013.03.058","article-title":"Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy","volume":"65","author":"Punnen","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.003_b0025","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1002\/cncr.26169","article-title":"The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy","volume":"117","author":"Cooperberg","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2026.03.003_b0030","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/jnci\/djp122","article-title":"Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis","volume":"101","author":"Cooperberg","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euo.2026.03.003_b0035","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.juro.2014.12.020","article-title":"External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort","volume":"193","author":"Tilki","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.03.003_b0040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.eururo.2014.05.004","article-title":"A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling","volume":"66","author":"Klein","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.003_b0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.eururo.2017.09.013","article-title":"A biopsy-based 17-gene Genomic Prostate Score as a predictor of metastases and prostate cancer death in surgically treated men with clinically localized disease","volume":"73","author":"Van Den Eeden","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.003_b0050","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1200\/jco.2012.30.15_suppl.4560","article-title":"Development of a needle biopsy-based genomic test to improve discrimination of clinically aggressive from indolent prostate cancer","volume":"30","author":"Klein","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2026.03.003_b0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.eururo.2014.11.030","article-title":"A biopsy-based 17-gene Genomic Prostate Score predicts recurrence after radical prostatectomy and adverse surgical pathology in a racially diverse population of men with clinically low- and intermediate-risk prostate cancer","volume":"68","author":"Cullen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.003_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273782","article-title":"The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer","volume":"17","author":"Helfand","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2026.03.003_b0065","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.euf.2021.03.015","article-title":"Association between Oncotype DX genomic prostate score and adverse tumor pathology after radical prostatectomy","volume":"8","author":"Covas Moschovas","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2026.03.003_b0070","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/JU.0000000000000290","article-title":"A 17-gene genomic prostate score as a predictor of adverse pathology in men on active surveillance","volume":"202","author":"Kornberg","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.03.003_b0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.64364\/tier.10104","article-title":"Retrograde nerve-sparing for large prostates: a step-by-step technique refined through experience with over 19,000 cases","volume":"1","author":"Ozawa","year":"2025","journal-title":"Theater Endourol Robot"},{"key":"10.1016\/j.euo.2026.03.003_b0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.eururo.2020.11.042","article-title":"Comparing the approach to radical prostatectomy using the multiport da VINCI Xi and da VINCI SP robots: a propensity score analysis of perioperative outcomes","volume":"79","author":"Moschovas","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.003_b0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.eururo.2013.08.022","article-title":"Optimal definition of biochemical recurrence after radical prostatectomy depends on pathologic risk factors: identifying candidates for early salvage therapy","volume":"66","author":"Mir","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.003_b0090","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/sim.6370","article-title":"Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach","volume":"34","author":"Kang","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.euo.2026.03.003_b0095","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1198\/106186006X133933","article-title":"Unbiased recursive partitioning: a conditional inference framework","volume":"15","author":"Hothorn","year":"2006","journal-title":"J Comput Graph Stat"},{"key":"10.1016\/j.euo.2026.03.003_b0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.eururo.2018.12.014","article-title":"Guidelines for reporting of statistics for clinical research in urology","volume":"75","author":"Assel","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.003_b0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eururo.2023.04.027","article-title":"Guidelines for reporting observational research in urology: the importance of clear reference to causality","volume":"84","author":"Vickers","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.003_b0110","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid, Spain 2025. ISBN 978-94-92671-29-5."},{"key":"10.1016\/j.euo.2026.03.003_b0115","unstructured":"NCCN Guidelines. NCCN guideline: National Comprehensive Cancer Network. version 3; 2026: Prostate Cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Accessed November 10, 2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"key":"10.1016\/j.euo.2026.03.003_b0120","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.19.02768","article-title":"Molecular biomarkers in localized prostate cancer: ASCO guideline","volume":"38","author":"Eggener","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2026.03.003_b0125","doi-asserted-by":"crossref","first-page":"19690","DOI":"10.1002\/cam4.6615","article-title":"Impact of genomic testing on urologists\u2019 treatment preference in favorable risk prostate cancer: a randomized trial","volume":"12","author":"Carbunaru","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.euo.2026.03.003_b0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.urology.2018.12.016","article-title":"Cost effectiveness of the Oncotype DX Genomic Prostate Score for guiding treatment decisions in patients with early stage prostate cancer","volume":"126","author":"Chang","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.euo.2026.03.003_b0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijrobp.2022.06.101","article-title":"The 17-gene Genomic Prostate Score test is prognostic for outcomes after primary external beam radiation therapy in men with clinically localized prostate cancer","volume":"115","author":"Janes","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2026.03.003_b0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/pcan.2013.49","article-title":"A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy","volume":"17","author":"Ross","year":"2014","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2026.03.003_b0145","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1200\/JCO.20.02997","article-title":"Impact of a genomic test on treatment decision in a predominantly African American population with favorable-risk prostate cancer: a randomized trial","volume":"39","author":"Murphy","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2026.03.003_b0150","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7326\/ANNALS-24-00700","article-title":"Impact of genomic classifiers on risk stratification and treatment intensity in patients with localized prostate cancer: a systematic review","volume":"178","author":"Tabriz","year":"2025","journal-title":"Ann Intern Med"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:32:36Z","timestamp":1793525556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2588931126000623"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.03.003","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating Genomic Prostate Score with Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores to Predict Biochemical Recurrence after Radical Prostatectomy","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}